HEADER TRANSLATION 12-FEB-07 2JGB TITLE STRUCTURE OF HUMAN EIF4E HOMOLOGOUS PROTEIN 4EHP WITH M7GTP COMPND MOL_ID: 1; COMPND 2 MOLECULE: EUKARYOTIC TRANSLATION INITIATION FACTOR 4E TYPE 2; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RESIDUES 45-234; COMPND 5 SYNONYM: EIF4E TYPE 2, EIF-4E TYPE 2, MRNA CAP-BINDING PROTEIN TYPE COMPND 6 3, EUKARYOTIC TRANSLATION INITIATION FACTOR 4E-LIKE 3, EUKARYOTIC COMPND 7 TRANSLATION INITIATION FACTOR 4E HOMOLOGOUS PROTEIN, MRNA CAP-BINDING COMPND 8 PROTEIN 4EHP, EIF4E-LIKE PROTEIN 4E-LP, EUKARYOTIC INITITIATION COMPND 9 FACTOR 4E HOMOLOGOUS PROTEIN; COMPND 10 ENGINEERED: YES; COMPND 11 MOL_ID: 2; COMPND 12 MOLECULE: EUKARYOTIC TRANSLATION INITIATION FACTOR 4E-BINDING PROTEIN COMPND 13 1; COMPND 14 CHAIN: B; COMPND 15 FRAGMENT: RESIDUES 50-66; COMPND 16 SYNONYM: 4E-BP1, EIF4E-BINDING PROTEIN 1, PHOSPHORYLATED HEAT- AND COMPND 17 ACID-STABLE PROTEIN REGULATED BY INSULIN 1, PHAS-I, EIF4E BINDING COMPND 18 PROTEIN; COMPND 19 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_PLASMID: PGEX-6P2; SOURCE 8 MOL_ID: 2; SOURCE 9 SYNTHETIC: YES; SOURCE 10 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 11 ORGANISM_COMMON: HUMAN; SOURCE 12 ORGANISM_TAXID: 9606 KEYWDS PHOSPHORYLATION, INITIATION FACTOR, 4EHP, EIF4E, RNA-BINDING, KEYWDS 2 ACETYLATION, CAP-BINDING, EUKARYOTIC INITIATION FACTOR, PROTEIN KEYWDS 3 SYNTHESIS INHIBITOR, TRANSLATION, PROTEIN BIOSYNTHESIS, TRANSLATION KEYWDS 4 REGULATION EXPDTA X-RAY DIFFRACTION AUTHOR A.D.CAMERON,P.ROSETTANI,S.KNAPP,M.G.VISMARA,L.RUSCONI REVDAT 7 13-DEC-23 2JGB 1 REMARK REVDAT 6 28-MAR-18 2JGB 1 SOURCE JRNL REVDAT 5 24-FEB-09 2JGB 1 VERSN REVDAT 4 29-JAN-08 2JGB 1 JRNL REMARK REVDAT 3 17-APR-07 2JGB 1 JRNL REVDAT 2 03-APR-07 2JGB 1 AUTHOR JRNL REVDAT 1 27-FEB-07 2JGB 0 JRNL AUTH P.ROSETTANI,S.KNAPP,M.G.VISMARA,L.RUSCONI,A.D.CAMERON JRNL TITL STRUCTURES OF THE HUMAN EIF4E HOMOLOGOUS PROTEIN, H4EHP, IN JRNL TITL 2 ITS M7GTP-BOUND AND UNLIGANDED FORMS. JRNL REF J. MOL. BIOL. V. 368 691 2007 JRNL REFN ISSN 0022-2836 JRNL PMID 17368478 JRNL DOI 10.1016/J.JMB.2007.02.019 REMARK 2 REMARK 2 RESOLUTION. 1.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0005 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 51.92 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 3 NUMBER OF REFLECTIONS : 23859 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.204 REMARK 3 R VALUE (WORKING SET) : 0.202 REMARK 3 FREE R VALUE : 0.242 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1262 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.70 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.74 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1692 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.3090 REMARK 3 BIN FREE R VALUE SET COUNT : 102 REMARK 3 BIN FREE R VALUE : 0.3560 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1665 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 33 REMARK 3 SOLVENT ATOMS : 193 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 17.90 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 18.37 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.53000 REMARK 3 B22 (A**2) : -0.49000 REMARK 3 B33 (A**2) : -0.04000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.119 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.118 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.078 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.315 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.943 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.924 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 1743 ; 0.013 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2363 ; 1.494 ; 1.966 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 200 ; 5.991 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 84 ;32.425 ;22.619 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 299 ;13.642 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 17 ;19.504 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 244 ; 0.098 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1322 ; 0.006 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 786 ; 0.209 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1164 ; 0.305 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 185 ; 0.143 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 50 ; 0.231 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 17 ; 0.106 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1047 ; 1.153 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1640 ; 1.697 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 826 ; 2.492 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 723 ; 3.979 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. RESIDUES 225 TO 227 OF THE PROTEIN CANNOT BE OBSERVED. REMARK 4 REMARK 4 2JGB COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 12-FEB-07. REMARK 100 THE DEPOSITION ID IS D_1290031412. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 26-JUN-05 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-D REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU IMAGE PLATE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 111967 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.700 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : 4.500 REMARK 200 R MERGE (I) : 0.06000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 17.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.79 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.2 REMARK 200 DATA REDUNDANCY IN SHELL : 4.40 REMARK 200 R MERGE FOR SHELL (I) : 0.37000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 1IPB REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.50 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20% PEG-3000, 0.1M SODIUM CITRATE PH REMARK 280 5.5 WITH 1MM M7GTP IN THE DROP REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 21.74950 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 51.88350 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 24.64950 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 51.88350 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 21.74950 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 24.64950 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 TOTAL BURIED SURFACE AREA: 2670 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 13560 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -11.2 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 40 REMARK 465 PRO A 41 REMARK 465 LEU A 42 REMARK 465 HIS A 43 REMARK 465 MET A 44 REMARK 465 GLY A 225 REMARK 465 ARG A 226 REMARK 465 LEU A 227 REMARK 465 VAL B 67 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O ILE A 211 O HOH A 2147 2.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MGT B1000 REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE INITIAL GPLHM HAS BEEN INTRODUCED DURING THE CLONING. REMARK 999 RESIDUES 44 TO 234 REMARK 999 RESIDUES 51 TO 67 DBREF 2JGB A 40 44 PDB 2JGB 2JGB 40 44 DBREF 2JGB A 45 234 UNP O60573 IF4E2_HUMAN 45 234 DBREF 2JGB B 51 67 UNP Q13541 4EBP1_HUMAN 50 66 SEQRES 1 A 195 GLY PRO LEU HIS MET LYS ALA VAL VAL PRO GLY PRO ALA SEQRES 2 A 195 GLU HIS PRO LEU GLN TYR ASN TYR THR PHE TRP TYR SER SEQRES 3 A 195 ARG ARG THR PRO GLY ARG PRO THR SER SER GLN SER TYR SEQRES 4 A 195 GLU GLN ASN ILE LYS GLN ILE GLY THR PHE ALA SER VAL SEQRES 5 A 195 GLU GLN PHE TRP ARG PHE TYR SER HIS MET VAL ARG PRO SEQRES 6 A 195 GLY ASP LEU THR GLY HIS SER ASP PHE HIS LEU PHE LYS SEQRES 7 A 195 GLU GLY ILE LYS PRO MET TRP GLU ASP ASP ALA ASN LYS SEQRES 8 A 195 ASN GLY GLY LYS TRP ILE ILE ARG LEU ARG LYS GLY LEU SEQRES 9 A 195 ALA SER ARG CYS TRP GLU ASN LEU ILE LEU ALA MET LEU SEQRES 10 A 195 GLY GLU GLN PHE MET VAL GLY GLU GLU ILE CYS GLY ALA SEQRES 11 A 195 VAL VAL SER VAL ARG PHE GLN GLU ASP ILE ILE SER ILE SEQRES 12 A 195 TRP ASN LYS THR ALA SER ASP GLN ALA THR THR ALA ARG SEQRES 13 A 195 ILE ARG ASP THR LEU ARG ARG VAL LEU ASN LEU PRO PRO SEQRES 14 A 195 ASN THR ILE MET GLU TYR LYS THR HIS THR ASP SER ILE SEQRES 15 A 195 LYS MET PRO GLY ARG LEU GLY PRO GLN ARG LEU LEU PHE SEQRES 1 B 17 ARG ILE ILE TYR ASP ARG LYS PHE LEU MET GLU CYS ARG SEQRES 2 B 17 ASN SER PRO VAL HET MGT B1000 33 HETNAM MGT 7N-METHYL-8-HYDROGUANOSINE-5'-TRIPHOSPHATE FORMUL 3 MGT C11 H20 N5 O14 P3 FORMUL 4 HOH *193(H2 O) HELIX 1 1 SER A 74 ASN A 81 1 8 HELIX 2 2 VAL A 91 SER A 99 1 9 HELIX 3 3 ARG A 103 LEU A 107 5 5 HELIX 4 4 LEU A 143 GLY A 157 1 15 HELIX 5 5 ASP A 189 LEU A 204 1 16 HELIX 6 6 HIS A 217 MET A 223 1 7 HELIX 7 7 ASP B 55 CYS B 62 1 8 HELIX 8 8 ARG B 63 SER B 65 5 3 SHEET 1 AA 7 ILE A 82 SER A 90 0 SHEET 2 AA 7 PRO A 55 ARG A 67 -1 N LEU A 56 O ALA A 89 SHEET 3 AA 7 HIS A 110 LYS A 117 -1 O HIS A 110 N ARG A 67 SHEET 4 AA 7 ILE A 166 VAL A 173 -1 O CYS A 167 N LYS A 117 SHEET 5 AA 7 ASP A 178 ASN A 184 -1 O ILE A 179 N SER A 172 SHEET 6 AA 7 GLY A 133 LEU A 139 -1 O GLY A 133 N ASN A 184 SHEET 7 AA 7 MET A 212 THR A 216 -1 O GLU A 213 N ILE A 136 SITE 1 AC1 16 ARG A 67 THR A 73 TYR A 78 HIS A 110 SITE 2 AC1 16 MET A 123 TRP A 124 GLU A 125 ARG A 174 SITE 3 AC1 16 PHE A 234 HOH A2018 HOH B2028 HOH B2029 SITE 4 AC1 16 HOH B2030 HOH B2031 HOH B2032 HOH B2033 CRYST1 43.499 49.299 103.767 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.022989 0.000000 0.000000 0.00000 SCALE2 0.000000 0.020284 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009637 0.00000